Update on the management of hyperthyroidism and hypothyroidism.
作者： Kenneth A. Woeber
DOI: 10.1001/ARCHINTE.160.8.1067
关键词:
摘要: Clinical aspects, laboratory investigation, and treatment of hyperthyroidism hypothyroidism are reviewed in light recent information. Special circumstances, such as during pregnancy, Graves ophthalmopathy, iodine-induced hyperthyroidism, subclinical hypothyroidism, also considered.
sci-hub.se 参考文章(24)
Susan L. Greenspan, The Effect of Thyroid Hormone on Skeletal Integrity Annals of Internal Medicine. ,vol. 130, pp. 750- 758 ,(1999) , 10.7326/0003-4819-130-9-199905040-00016
Fereidoun Azizi, Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants The Journal of Pediatrics. ,vol. 128, pp. 855- 858 ,(1996) , 10.1016/S0022-3476(96)70342-6
R. H. Mortimer, G. R. Cannell, R. S. Addison, L. P. Johnson, M. S. Roberts, I. Bernus, Methimazole and Propylthiouracil Equally Cross the Perfused Human Term Placental Lobule* The Journal of Clinical Endocrinology & Metabolism. ,vol. 82, pp. 3099- 3102 ,(1997) , 10.1210/JCEM.82.9.4210
Christophe Trivalle, Jean Doucet, Philippe Chassagne, Isabelle Landrin, Nadir Kadri, Jean-François Menard, Eric Bercoff, Differences in the Signs and Symptoms of Hyperthyroidism in Older and Younger Patients Journal of the American Geriatrics Society. ,vol. 44, pp. 50- 53 ,(1996) , 10.1111/J.1532-5415.1996.TB05637.X
Roger S. Rittmaster, E. Carl Abbott, Robert Douglas, Morris L. Givner, Lea Lehmann, Sethu Reddy, Sonia R. Salisbury, Allan H. Shlossberg, Meng H. Tan, Samuel E. York, Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease. The Journal of Clinical Endocrinology and Metabolism. ,vol. 83, pp. 814- 818 ,(1998) , 10.1210/JCEM.83.3.4613
H Tamai, I Hayaki, K Kawai, G Komaki, S Matsubayashi, K Kuma, L F Kumagai, S Nagataki, Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. The Journal of Clinical Endocrinology & Metabolism. ,vol. 80, pp. 1481- 1484 ,(1995) , 10.1210/JCEM.80.5.7744989
ROGER BERNSTEIN, CARL MÜLLER, KJELL MIDTB, GUNNAR SMITH, EGIL HAUG, LEIF HERTZENBERG, Silent myocardial ischemia in hypothyroidism. Thyroid. ,vol. 5, pp. 443- 447 ,(1995) , 10.1089/THY.1995.5.443
Peter A. Singer, Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism JAMA: The Journal of the American Medical Association. ,vol. 273, pp. 808- 812 ,(1995) , 10.1001/JAMA.1995.03520340064038
A. Lucas, I. Salinas, F. Rius, E. Pizarro, M.L. Granada, M. Foz, A. SanmartÍ, Medical Therapy of Graves’ Disease: Does Thyroxine Prevent Recurrence of Hyperthyroidism? The Journal of Clinical Endocrinology and Metabolism. ,vol. 82, pp. 2410- 2413 ,(1997) , 10.1210/JCEM.82.8.4118
Bryan McIver, Peter Rae, Geoffrey Beckett, Ewan Wilkinson, Ann Gold, Anthony Toft, Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. The New England Journal of Medicine. ,vol. 334, pp. 220- 224 ,(1996) , 10.1056/NEJM199601253340403